MedTrace Logo

Prevalence and Management Practice of Diabetic Kidney Disease at BADAS Affiliated Healthcare Centres in Bangladesh

NCT06422598 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 320

Last updated 2024-05-21

No results posted yet for this study

Summary

Background: Diabetes is a growing public health concern in Bangladesh, with millions affected. Diabetic Kidney Disease (DKD) is a severe complication of diabetes, affecting approximately 21.3% of the diabetic population. To address this issue, a comprehensive assessment of DKD within the Bangladesh Diabetic Association\'s (BADAS) affiliated healthcare centres is necessary.

Objective: The study\'s general objective is to determine the prevalence of DKD and evaluate its management at BADAS-affiliated healthcare centers. Specific objectives include assessing risk factors, screening practices, disease staging, management approaches, patient education, and providing evidence-based recommendations.

Methodology:

* Study Design: Cross-sectional
* Study Population: All diabetic patients at BADAS-affiliated centers
* Exclusion Criteria: Patients unwilling to participate or with kidney disease from other causes and with acute illness
* Sample Size: \"Forty patients will be selected from each center, resulting in a total sample size of 320 patients across eight centers, with one center randomly selected from each of the eight divisions in Bangladesh.\"
* Data Collection: Demographics, comorbidities, kidney function, blood pressure, HbA1c levels, medication records, treatment guideline adherence
* Data Analysis: prevalence of diabetic kidney disease, factors affecting management, and potential barriers
* Ethical Considerations: Ensure patient data privacy, obtain approvals, and informed consent Implications: The study aims to provide insights into the current state of magnitude (prevalence) of DKD, its management, highlighting areas for improvement in patient care, guideline adherence, and ultimately enhancing the well-being of diabetic patients in Bangladesh.

Conditions

  • Diabetic Kidney Disease

Sponsors & Collaborators

  • Ibrahim Medical College

    collaborator UNKNOWN

  • Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders

    lead OTHER

Principal Investigators

  • Wasim MM Haque, MBBS, FCPS · Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-11
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • Bangladesh

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06422598 on ClinicalTrials.gov